Potential of FTIR spectroscopy applied to exosomes for Alzheimer’s disease discrimination: a pilot study

Alzheimer's disease (AD) diagnosis is based on psychological and imaging tests but can also include monitoring cerebrospinal fluid (CSF) biomarkers. However, CSF based-neurochemical approaches are expensive and invasive, limiting their use to well-equipped settings. In contrast, blood-based bio...

Full description

Bibliographic Details
Main Author: Soares Martins, Tânia (author)
Other Authors: Magalhães, Sandra (author), Rosa, Ilka Martins (author), Vogelgsang, Jonathan (author), Wiltfang, Jens (author), Delgadillo, Ivonne (author), Catita, José António Morais (author), da Cruz e Silva, Odete A.B. (author), Nunes, Alexandra (author), Henriques, Ana Gabriela (author)
Format: article
Language:eng
Published: 2022
Subjects:
Exosomes
Blood
Serum
Alzheimer’s disease
Biomarker
Diagnosis
Online Access:http://hdl.handle.net/10284/10680
Country:Portugal
Oai:oai:bdigital.ufp.pt:10284/10680

Internet

http://hdl.handle.net/10284/10680

Similar Items